BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9972639)

  • 41. Atypical neuroleptic malignant syndrome associated with iloperidone administration.
    Guanci N; Aggarwal R; Schleifer S
    Psychosomatics; 2012; 53(6):603-5. PubMed ID: 23157999
    [No Abstract]   [Full Text] [Related]  

  • 42. Neuroleptic malignant syndrome and risperidone: a case report.
    Bonwick RJ; Hopwood MJ; Morris PL
    Aust N Z J Psychiatry; 1996 Jun; 30(3):419-21. PubMed ID: 8839956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risperidone and neuroleptic malignant syndrome.
    Tarsy D
    JAMA; 1996 Feb; 275(6):446. PubMed ID: 8627964
    [No Abstract]   [Full Text] [Related]  

  • 44. Risperidone-induced anxiety might also develop 'awakening' phenomenon.
    Hori M; Shiraishi H
    Psychiatry Clin Neurosci; 1999 Dec; 53(6):682. PubMed ID: 10687752
    [No Abstract]   [Full Text] [Related]  

  • 45. Delayed risperidone-induced neuroleptic malignant syndrome.
    Kern JL; Cernek PK
    Ann Pharmacother; 1996 Mar; 30(3):300. PubMed ID: 8833573
    [No Abstract]   [Full Text] [Related]  

  • 46. [Neuroleptic malignant syndrome associated with olanzapine].
    García López MM; Ciprés L; de Cendra E; Vilalta Franch J
    Med Clin (Barc); 1999 Sep; 113(6):239. PubMed ID: 10472615
    [No Abstract]   [Full Text] [Related]  

  • 47. Neuroleptic malignant syndrome.
    Bhattacharyya K
    J Assoc Physicians India; 1999 Sep; 47(9):940. PubMed ID: 10778680
    [No Abstract]   [Full Text] [Related]  

  • 48. Delirium with dystonia: a variant of neuroleptic malignant syndrome?
    Dowling JJ; Patrick V
    Am J Psychiatry; 1989 Feb; 146(2):276-7. PubMed ID: 2563212
    [No Abstract]   [Full Text] [Related]  

  • 49. Risperidone and neuroleptic malignant syndrome. Recognizing a potentially fatal condition.
    Shuster J
    Nursing; 1997 Mar; 27(3):68. PubMed ID: 9171635
    [No Abstract]   [Full Text] [Related]  

  • 50. Cannabis and psychosis.
    Spencer J
    Aust N Z J Psychiatry; 2000 Aug; 34(4):700. PubMed ID: 10954410
    [No Abstract]   [Full Text] [Related]  

  • 51. Neuroleptic malignant syndrome is malignant catatonia, warranting treatments efficacious for catatonia.
    Fink M; Taylor MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1182-3; author reply 1184-5. PubMed ID: 16675086
    [No Abstract]   [Full Text] [Related]  

  • 52. Risperidone-induced neuroleptic malignant syndrome.
    Sharma R; Trappler B; Ng YK; Leeman CP
    Ann Pharmacother; 1996; 30(7-8):775-8. PubMed ID: 8826559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dantrolene in lethal catatonia.
    Pennati A; Sacchetti E; Calzeroni A
    Am J Psychiatry; 1991 Feb; 148(2):268. PubMed ID: 1670981
    [No Abstract]   [Full Text] [Related]  

  • 54. Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
    Kosehasanogullari SG; Akdede B; Akvardar Y; Akan M; Tunca Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1147-8. PubMed ID: 17513032
    [No Abstract]   [Full Text] [Related]  

  • 55. Further observations on the neuroleptic malignant syndrome.
    Lazarus A; Lipschutz LB
    J Clin Psychopharmacol; 1991 Apr; 11(2):148-9. PubMed ID: 1676039
    [No Abstract]   [Full Text] [Related]  

  • 56. Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescents.
    Zalsman G; Lewis R; Konas S; Loebstein O; Goldberg P; Burguillo F; Nahshoni E; Munitz H
    Int J Adolesc Med Health; 2004; 16(2):179-82. PubMed ID: 15266995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment.
    Oglodek E; Szota A; Araszkiewicz A
    Aust N Z J Psychiatry; 2013 Oct; 47(10):972. PubMed ID: 23630396
    [No Abstract]   [Full Text] [Related]  

  • 58. Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone.
    Teng PR; Lane HY
    J Neuropsychiatry Clin Neurosci; 2011; 23(4):E16-7. PubMed ID: 22231327
    [No Abstract]   [Full Text] [Related]  

  • 59. Neuroleptic malignant syndrome associated with clozapine monotherapy.
    Thornberg SA; Ereshefsky L
    Pharmacotherapy; 1993; 13(5):510-4. PubMed ID: 8247922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuroleptic malignant syndrome in a man with mental retardation.
    McNally RJ; Calamari JE
    Ment Retard; 1988 Dec; 26(6):385-6. PubMed ID: 3237069
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.